Elanco Animal Health is an animal health company that innovates, develops, manufactures, and markets products for pets and farm animals. Co. groups its products into two principal categories: Pet Health and Farm Animal. Co.'s pet health portfolio is focused on parasiticides, vaccines and therapeutics. Co. has one parasiticide portfolio in the pet health sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. Co.'s farm animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle (beef and dairy), swine, poultry, and aquaculture (cold and warm water) production. The ELAT average annual return since 2020 is shown above.
The Average Annual Return on the ELAT average annual return since 2020 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether ELAT average annual return since 2020 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ELAT average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|